FGF21 hormone, key to control obesity, also protects against heart diseases in mice

A research group has found that FGF21, an endocrine factor which reduces glucose levels, protects against cardiac diseases in mice. The research, published online on the journal Nature Communications, was led by Francesc Villarroya, professor from the Department of Biochemistry and Molecular Biology of the UB and Director of the Institute of Biomedicine of the University of Barcelona (IBUB), affiliated centre with the campus of international excellence BKC. Anna Planavila, first author of the paper, from that Department of the UB, the experts Luigi Gabrielli and Marta Sitges (IDIBAPS-Hospital Clínic de Barcelona) and other international experts also collaborated in the research.

Fibroblast growth factor 21 (FGF21), mainly secreted by the liver, is a protein which acts as a metabolic regulator and plays a key role as an antidiabetic and antiobesity agent. In 2010, the cover of the journal Cell Metabolism echoed a finding made by the UB research group headed by Dr Villarroya: FGF21 activates thermogenesis in brown adipose tissue —which governs energy expenditure and heat production in the body—, what promotes the burning of calories to release heat, dissipating then large amounts of energy.

FGF21: a cardioprotective agent in mice

According to Professor Francesc Villarroya, member of the Biomedical Research Networking Centres on Physiopathology of Obesity and Nutrition (CIBERobn), "the research has contributed to describe the protecting role against cardiac hypertrophy that FGF21 plays in mice". The research group compared the role of FGF21 in in a group of (those lacking FGF21) and in another group which perfectly express the factor. They observed that mice lacking FGF21 are more prone to develop .

Anna Planavila, expert on metabolism and cardiac functions study, explains that "echocardiography tests, carried out together with a group from Hospital Clínic, proved how knock-out mice's had got worse as they showed dilatation and , electrocardiography waves due to alterations of the mechanisms of cardiac systole and diastole mechanisms, etc. These effects were also observed at histological and gene expression levels".

The heart is able to produce FG21

Besides FGF21 new function, the paper reveals new scientific findings about cardiac metabolism and physiology. Authors affirm that the heart is also able to produce this factor which works as a protective agent against heart stress situations. "Previous knowledge —Villarroya adds— had already stated that FGF21 is synthetized by the liver, the skeletal muscle and the brown adipose tissue to speed up glucose uptake and energy metabolism. The research has also unveiled that the cardiac muscle produces the endocrine factor too". Experts state that the heart produces the factor under basal conditions. If the heart undergoes more physiological stress, FGF21 production is increased as a protective response. "Unlike the liver, the skeletal muscle and the , cardiac cells ability to produce this factor has a local and self-protection effect", Villarroya remarks. The pre-clinical study published on Nature Communications shed new light on the metabolic control of molecular signalling pathways of diabetes, obesity and adipose tissue inflammation. The research can contribute to establish FGF21 as a potential tool in the development of new strategies to prevent and treat cardiac damage.

More information: Planavila, A. et al. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice, Nature Communications, Volume:4, Article number:2019 DOI:10.1038/ncomms3019.

Related Stories

Mother's milk turns on the heat

Mar 02, 2010

In newborn mice, at least, mother's milk appears to have some rather immediate and potentially far-reaching metabolic consequences. The milk intake kick-starts the liver to produce a molecule that then turns on heat-generating ...

Antibody injection promising for diabetes and obesity

Dec 16, 2011

(Medical Xpress) -- Researchers at Genetech Inc. in South San Francisco, California, led by molecular biologist Junichiro Sonoda, have discovered that a single injection of antibodies into obese diabetic mice provided a marked ...

Starvation hormone makes for small mice

Jun 26, 2008

Chronically high levels of a recently discovered starvation hormone markedly stunt the growth of mice, reveals a new study in the July issue of Cell Metabolism, a publication of Cell Press. The liver-produced hormone known ...

Recommended for you

Most seniors eligible for statin Rx under new guidelines

Nov 25, 2014

(HealthDay)—Most older Americans qualify for treatment with statins under new guidelines for the treatment of blood cholesterol released late last year by the American College of Cardiology and the American ...

Asymptomatic atherosclerosis linked to cognitive impairment

Nov 25, 2014

In a study of nearly 2,000 adults, researchers found that a buildup of plaque in the body's major arteries was associated with mild cognitive impairment. Results of the study conducted at the University of Texas (UT) Southwestern ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.